ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
63,223.95
-0.81%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. IN8bio Inc (INAB) Quote

IN8bio Inc

IN8bio Inc (INAB)

NASDAQ
1.04
0.00
(0.00%)
Closed April 27 4:00PM
Delayed by 15 minutes
1.00
-0.04
(-3.85%)
After Hours: 7:59PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.04
Bid
0.99
Ask
1.03
Volume
55,917
0.99 Day's Range 1.03
0.65 52 Week Range 3.48
Market Cap
43.287M
Previous Close
1.04
Open
1.03
Last Trade
328
@
1.04
Last Trade Time
Financial Volume
$ 56,338
VWAP
1.0075
Average Volume (3m)
342,469
Shares Outstanding
43,287,325
Dividend Yield
-
PE Ratio
-1.44
Earnings Per Share (EPS)
-0.69
Revenue
-
Net Profit
-30.01M

About IN8bio Inc

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.in8bio.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $1.04. Over the last year, IN8bio shares have traded in a share price range of $ 0.65 to $ 3.48.

IN8bio currently has 43,287,325 shares outstanding. The market capitalization of IN8bio is $43.29 million. IN8bio has a price to earnings ratio (PE ratio) of -1.44.

INAB Latest News

More News

IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an oral...

April 24 2024
GlobeNewswire Inc.

IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that...

April 16 2024
GlobeNewswire Inc.

IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024

- Preclinical data supports potential for proprietary nsCAR platform to selectively eliminate cancer cells while preserving healthy tissue - Gamma-delta nsCAR platform emerging as an advanced...

April 09 2024
GlobeNewswire Inc.

IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

Reported the First-Ever Durable Persistence of an Allogeneic Cellular Therapy from a Phase 1 Study of INB-100 in Leukemia where 100% of Evaluable Patients (n=10) Treated Remained in Remission...

March 14 2024
GlobeNewswire Inc.

IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024

New preclinical data demonstrating proof-of-concept for the non-signaling gamma-delta T cell CAR (nsCAR) platform candidate targeting CD-33 and CD-123 will be presented.The platform has...

March 05 2024
GlobeNewswire Inc.

IN8bio to Present at Upcoming Investor Conferences

IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced that William Ho, CEO and Co-founder, will...

February 26 2024
Business Wire

IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ: INAB), a leading clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced a...

February 14 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

February 08 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 08 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 08 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.021.960784313731.021.090.942008521.03149861CS
4-0.13-11.11111111111.171.21990.91647009221.09321786CS
12-0.24-18.751.281.450.91643424691.11985637CS
260.1314.28571428570.912.480.654870921.38957637CS
52-0.96-4823.480.654974601.67538973CS
156-8.96-89.61010.3190.655978712.53544622CS
260-8.96-89.61010.3190.655978712.53544622CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

INAB Discussion

View Posts
Tyrus603 Tyrus603 2 weeks ago
Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.
👍️0
Laster Laster 2 weeks ago
Sold my shares this morning that I bought last night for small loss.
Volume not great. No PM movement (yet).
Who knows. It may surprise and take off at 9:30 open.
If it does, then congrats to y’all.
👍️0
Invest-in-America Invest-in-America 3 weeks ago
INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

BOTTOM LINE??? GO-GO-GO-INAB!!!!
👍️0
glenn1919 glenn1919 2 months ago
INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
INAB under $2
👍️0
murocman murocman 4 months ago
Surprised how much this has tanked in light of stellar data?

Murocman
👍️0
murocman murocman 5 months ago
Outstanding data and financing in place to boot!

Should move up!

Murocman
👍️0
Awl416 Awl416 5 months ago
IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia
👍️0
Monksdream Monksdream 7 months ago
INAB under $2
👍️0
Monksdream Monksdream 7 months ago
INAB new 52 week low
👍️0
Monksdream Monksdream 8 months ago
INAB new 52 week low
👍️0
The Night Stalker The Night Stalker 10 months ago
https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
👍️0
The Night Stalker The Night Stalker 10 months ago
like this
👍️0
The Night Stalker The Night Stalker 10 months ago
like this
👍️0
The Night Stalker The Night Stalker 10 months ago
looks good
👍️0
The Night Stalker The Night Stalker 11 months ago
dip
👍️0
The Night Stalker The Night Stalker 11 months ago
dip
👍️0
The Night Stalker The Night Stalker 11 months ago
nice
👍️0
The Night Stalker The Night Stalker 11 months ago
strong chart
👍️0
The Night Stalker The Night Stalker 11 months ago
reaDY
👍️0
The Night Stalker The Night Stalker 11 months ago
reaDY
👍️0
Mr Wick Mr Wick 11 months ago
New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
Fingers crossed.
👍️0
The Night Stalker The Night Stalker 11 months ago
nice
👍️0
MrMocha MrMocha 11 months ago
I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!
👍️ 1
Mr Wick Mr Wick 11 months ago
New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
Looking forward to a buyout.
👍️ 1
The Night Stalker The Night Stalker 11 months ago
right on
👍️0
The Night Stalker The Night Stalker 11 months ago
strong as hell
👍️0
Trons Trons 11 months ago
Headed to $20 on cancer developments
👍️0
Jess070283 Jess070283 1 year ago
Uh oh Shorts I’m trouble….
👍️0
trendzone trendzone 1 year ago
Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.
👍️0
Jess070283 Jess070283 1 year ago
Loading this dip for the rip…
👍️0
Invest-in-America Invest-in-America 1 year ago
INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)
👍️0
TheFinalCD TheFinalCD 1 year ago
Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
👍️0
subslover subslover 1 year ago
Love your scanner! :)
👍️0
2020Benzo 2020Benzo 1 year ago
Did they just post same Orphan Drug news twice in a row it’s sane PR !
👍️0
TheFinalCD TheFinalCD 1 year ago
sub $2
👍️0
surf1944 surf1944 1 year ago
https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/inab/opinion

Back down to $1
👍️0
ringo1 ringo1 1 year ago
Time to take some profits
👍️0
Hercules1 Hercules1 1 year ago
It hit $3.95.

$4 break is coming.


$5 quite possible today.
👍️0
Hercules1 Hercules1 1 year ago
Total beast.

Next stop $4.

And then $5.
👍️0
Awl416 Awl416 1 year ago
Impressive day
👍️0
Jess070283 Jess070283 1 year ago
What a beast!
👍️0
Invest-in-America Invest-in-America 1 year ago
INAB: Maybe I've gone BONKERS, but this little freak show could hit TEN-BUCKS-A-SHARE today, Peeps!!!! (At least that's what my 'SCANNER' just told me!! See below!!)

👍️0
Hercules1 Hercules1 1 year ago
This skyrockets to $5 today.

This is just getting started.


👍️0
Invest-in-America Invest-in-America 1 year ago
INAB: Howdy, Herc!!! Guess us TWO chaps will have to PARTY all by ourselves over here today on this silly little iHub Board!! Heck, I guess nobody else but US two could figure-out what INAB's cute PR was all about!! (HA-HAAAAAAA!!!)

Lastly, check-out what my 'BROKER' (see below) had to say to me about this INAB stock, very early this morning:
👍️0
Hercules1 Hercules1 1 year ago
Price target:

$14


News is absolutely huge.

👍️0
Invest-in-America Invest-in-America 1 year ago
INAB: This is iHub's legendary "INVEST-IN-AMERICA", with a very succinct DIRECT ORDER for INAB's entire High Seas Fleet --- to wit, OPEN-FIRE-NOW!!!

👍️0
Invest-in-America Invest-in-America 1 year ago
INAB: Might get a little run-up later today, when all of the insider dumping subsides. I mean heck, pretty decent PR.
https://seekingalpha.com/news/3959103-in8bio-stock-rises-cancer-drug-inb-100-shows-promise-phase-1-trial

👍️0

Your Recent History

NASDAQ
INAB
IN8bio
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved